Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_assertion type Assertion NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_head.
- NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_assertion description "[Confirmation of these findings is needed before the Kozak sequence variant can be accepted as a potential marker for personalized treatment of affective disorders with drugs targeting the metabotropic glutamate receptor 3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_provenance.
- NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_assertion evidence source_evidence_literature NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_provenance.
- NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_assertion SIO_000772 23575746 NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_provenance.
- NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_assertion wasDerivedFrom befree-2016 NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_provenance.
- NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_assertion wasGeneratedBy ECO_0000203 NP1068246.RAtVOE5bh8l-IIcm6q1AZCCg95Ips7j-3_z0DM48gbE_w130_provenance.